OB-GYN 101
Pharmacy

Contents  ·  Introduction  ·  Learning Objectives  ·  Clinical Issues  ·  Procedures  ·  Library  ·  Pharmacy  ·  Lab  ·  Chest X-ray  ·  Ultrasound  ·  Videos  ·  Forms  ·  Progress Notes  ·  Facts Cards  ·  Students  ·  Search  ·  Feedback  ·  About Us

 

 

Atenolol (Tenormin)

Category:

  • Nervous system

Description:

  • Antihypertensive, antianginal, class II antidysrhythmic: (beta blocker)

Indications:

  • Angina pectoris due to coronary atherosclerosis,

  • Hypertension, acute MI

  • Several non-FDA approved uses

Contraindications:

  • Cardiogenic shock, 2nd or 3rd degree heart block, sinus bradycardia

  • CHF unless secondary to a tachyarrhythmia treatable with beta-blockers, overt cardiac failure

Precautions:

  • Pregnancy category C

  • Major surgery, diabetes mellitus, renal disease, thyroid disease, COPD, asthma

  • Well compensated heart failure, abrupt withdrawal, peripheral vascular disease

  • Do not discontinue drug abruptly, may precipitate angina

Adverse Reactions (Side Effects):

  • CNS: depression, dizziness, drowsiness, fatigue, hallucinations, insomnia, lethargy, memory loss, mental changes, strange dreams

  • CV: bradycardia, CHF, cold extremities, postural hypotension, profound hypotension, 2nd and 3rd degree heart block

  • EENT: dry burning eyes, sore throat visual disturbances

  • GI: diarrhea, dry mouth, ischemic colitis, mesenteric arterial thrombosis, nausea, vomiting

  • GU: impotence, sexual dysfunction

  • HEME: agranulocytosis, thrombocytopenia

  • METAB: hyperglycemia, hyperlipidemia, masked hypoglycemic response

  • RESP: bronchospasm, dyspnea, wheezing

  • SKIN: alopecia, pruritis, rash  

 

 

 

Dosage:

Administered orally and intravenously

  • Adult: 

    • IV 

      • 5mg over 5 min

      • repeat in 10 minutes if initial dose is well tolerated

      • then start PO dose 10 minutes after last IV dose

    • PO 

      • 50mg daily

      • increase every 1-2 weeks to 100mg daily

      • may increase to 200mg daily for angina

  • Child: 

    • PO 

      • initial 1-1.2 mg/kg/dose given daily

      • maximum 2 mg/kg/day

 

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks. Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

OB-GYN 101: Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008 Medical Education Division, Brookside Associates, Ltd.
All rights reserved

 

 

 

Advertise on this site